Your browser doesn't support javascript.
loading
Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR-MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion-Driven NSCLC.
Yun, Jiyeon; Lee, Soo-Hwan; Kim, Seok-Young; Jeong, Seo-Yoon; Kim, Jae-Hwan; Pyo, Kyoung-Ho; Park, Chae-Won; Heo, Seong Gu; Yun, Mi Ran; Lim, Sangbin; Lim, Sun Min; Hong, Min Hee; Kim, Hye Ryun; Thayu, Meena; Curtin, Joshua C; Knoblauch, Roland E; Lorenzi, Matthew V; Roshak, Amy; Cho, Byoung Chul.
  • Yun J; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Lee SH; JE-UK Institute for Cancer Research, JEUK Co. Ltd., Gumi-City, Kyungbuk, Republic of South Korea.
  • Kim SY; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Jeong SY; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Kim JH; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Pyo KH; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Park CW; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Heo SG; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Yun MR; JE-UK Institute for Cancer Research, JEUK Co. Ltd., Gumi-City, Kyungbuk, Republic of South Korea.
  • Lim S; Severance Biomedical Science Institute, Brain Korea 21 PLUS Project for Medical Sciences, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Lim SM; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Hong MH; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Kim HR; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of South Korea.
  • Thayu M; Janssen Research and Development, Spring House, Pennsylvania.
  • Curtin JC; Janssen Research and Development, Spring House, Pennsylvania.
  • Knoblauch RE; Janssen Research and Development, Spring House, Pennsylvania.
  • Lorenzi MV; Janssen Research and Development, Spring House, Pennsylvania.
  • Roshak A; Janssen Research and Development, Spring House, Pennsylvania.
  • Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of South Korea. cbc1971@yuhs.ac.
Cancer Discov ; 10(8): 1194-1209, 2020 08.
Article en En | MEDLINE | ID: mdl-32414908
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Animals / Female / Humans Idioma: En Año: 2020 Tipo del documento: Article